Hypericin is an extract of Hypericum perforatum. It was first isolated from Hypericum perforatum in 1957 by humans. It is a dianthrone compound. It is the most biologically active substance in Hypericum perforatum. Its appearance is grayish yellow to Brown tan powder, slightly bitter taste, easily soluble in water, can emit special fragrance, has the effect of inhibiting central nerve and sedation, added to health products can enhance immunity, also in Europe (especially Germany) Used as an antidepressant. Hypericin also has a strong antiviral effect, which can directly act on swine fever, foot-and-mouth disease and other viruses, and also has a good killing effect on highly pathogenic avian influenza viruses.
Hypericin is an extract of Hypericum perforatum, which has a strong antiviral effect. As a new preparation for the prevention and treatment of avian influenza in the country, it has achieved good response and effects in all parts of the country; this clinical application once again proved the good effect of hypericin on the prevention and treatment of influenza virus. Due to the long-term vaccine prevention and drug treatment, the influenza virus gradually mutates, the clinical symptoms are atypical, and complicated with airbag inflammation, E. coli and other diseases. It is recommended that the clinical medications should be used in conjunction with corresponding Western medicines for more accurate results.
The inspection of the “killing effect of hypericin on avian influenza H5N1 and H9N2 subtype viruses” submitted to the National Avian Influenza Reference Laboratory by the Lanzhou Institute of Animal Husbandry and Veterinary Medicine of the Chinese Academy of Agricultural Sciences was completed a few days ago. The results show that hypericin has a good killing effect on highly pathogenic avian influenza virus, and the final killing rate can reach 100%.
Researcher Liang Jianping, director of the Lanzhou Institute of Animal Husbandry and Veterinary Medicine, Chinese Academy of Agricultural Sciences and the Key Laboratory of New Veterinary Medicine Engineering of the Ministry of Agriculture, said that the test report showed that hypericin and avian influenza virus H5N1 and H9N2 subtype viruses were in vitro at different concentrations. Direct contact, where the hypericin contains 3.72mg crude drug per ml, it can react with the avian influenza virus for 30 minutes, and the kill rate of the virus can reach 100%, within the concentration range of 0.744mg crude drug per ml, and The avian influenza virus acts for 10 minutes, and the kill rate of the virus can reach more than 99.99%.
The outbreak of highly pathogenic avian influenza has affected the economic operation of some Asian countries and caused heavy losses to animal husbandry production. For this reason, the Chinese government attaches great importance to it and has increased relevant scientific and technological research. It is undertaken by the Lanzhou Institute of Animal Husbandry and Veterinary Medicine of the Chinese Academy of Agricultural Sciences, and the National Science and Technology Project “Highly Pathogenic Avian Influenza Prevention and Control Technology Research and Development” participated by the Yunnan Institute of Ecological Agriculture is one of them.
Researcher Liang Jianping said that the main goal of the scientific research project is to extract hypericin, which can kill avian influenza virus, from Chinese herbal medicine Hypericum perforatum, and then make a Chinese herbal medicine compound preparation as the first choice for preventing viral diseases such as avian influenza. Through the efforts of scientific researchers, hypericin has been successfully extracted from Hypericum perforatum, and the lines and methods for artificial synthesis through chemical processes have been initially explored.
It is understood that in addition to the “Hyperin effect on the avian influenza H5N1 and H9N2 subtype virus killing” test, two important scientific tests related to it have also been completed and achieved good results. Researcher Liang Jianping said that the in vivo anti-avian influenza virus test of hypericin is expected to be completed. According to the current scientific research progress, by mid-2007, it is expected to realize the pilot production and industrial production of hypericin and put it on the market.
Hypericin induces apoptosis of cancer cells both in vitro and in vivo and is a powerful antiviral drug. Has antidepressant and antiviral effects. It can also be used as a veterinary medicine for chickens to prevent and control bird flu.
Hypericin is an antiviral pure Chinese medicine preparation, and is the first choice for preventing and treating avian influenza.
- Avian influenza, atypical Newcastle disease, transmission, larynx, bursal bursa, duck plague, duck viral hepatitis, egg production syndrome and other viral diseases.
- High fever caused by avian cold, difficulty breathing,
coughing, swelling of the head and face, purple hair, lack of energy, decreased feeding, decreased egg production, polymorphic egg production, etc.
- It is used for swine fever, blue ear disease, parvovirus, viral enteritis, infectious gastroenteritis, and immunodeficiency.
- Hypericin has a retroviral effect in vivo and in vitro, and has a strong antiviral effect. It has a strong inhibitory effect on the early replication of HIV. It can cause the programmed death of cancer cells and has an anti-cancer effect. It can activate mononuclear phagocytes, etc. It has the effect of enhancing immunity. It has a strong killing effect on highly pathogenic H5N1 and H9N2 subtype avian influenza viruses.
